REVIVA PHARMACEUTICALS HOLDINGS, INC. — All Filings
395 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
25-NSE
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
NT 10-K
POS AM
POS EX
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001214659-25-007880 | May 15, 2025 | — |
| 10-K | FORM 10-K | 0001437749-25-010791 | Apr 3, 2025 | Dec 31, 2024 |
| S-8 | FORM S-8 | 0001437749-25-010825 | Apr 3, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-010191 | Mar 31, 2025 | — |
| NT 10-K | FORM NT 10-K | 0001437749-25-010274 | Mar 31, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001437749-25-004224 | Feb 18, 2025 | Feb 13, 2025 |
| 4 | FORM 4 | 0001437749-25-004221 | Feb 18, 2025 | Feb 13, 2025 |
| 4 | FORM 4 | 0001437749-25-004220 | Feb 18, 2025 | Feb 13, 2025 |
| SCHEDULE 13G/A | — | 0001193805-25-000195 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001649553-25-000043 | Feb 7, 2025 | — |
| SCHEDULE 13D/A | — | 0001493152-25-004530 | Jan 31, 2025 | — |
| SCHEDULE 13G | — | 0001104659-24-131161 | Dec 23, 2024 | — |
| SCHEDULE 13D/A | — | 0001437749-24-038128 | Dec 20, 2024 | — |
| 424B5 | FORM 424B5 | 0001437749-24-037758 | Dec 18, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-037764 | Dec 18, 2024 | Dec 16, 2024 |
| 8-K | FORM 8-K | 0001437749-24-037520 | Dec 16, 2024 | — |
| 424B5 | FORM 424B5 | 0001437749-24-037646 | Dec 16, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-037373 | Dec 12, 2024 | Dec 10, 2024 |
| 4 | FORM 4 | 0001437749-24-037369 | Dec 12, 2024 | Dec 10, 2024 |
| 4 | FORM 4 | 0001437749-24-037371 | Dec 12, 2024 | Dec 10, 2024 |
| 4 | FORM 4 | 0001437749-24-037372 | Dec 12, 2024 | Dec 10, 2024 |
| 4 | FORM 4 | 0001437749-24-037370 | Dec 12, 2024 | Dec 10, 2024 |
| 10-Q | FORM 10-Q | 0001437749-24-035375 | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | — | 0001172661-24-005328 | Nov 14, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-035391 | Nov 14, 2024 | — |
| SC 13G | — | 0001193805-24-001374 | Nov 14, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-034338 | Nov 12, 2024 | — |
| DEF 14A | FORM DEF 14A | 0001437749-24-032297 | Oct 28, 2024 | Dec 10, 2024 |
| ARS | — | 0001437749-24-032298 | Oct 28, 2024 | Dec 31, 2023 |
| PRE 14A | FORM PRE 14A | 0001437749-24-031482 | Oct 17, 2024 | Dec 10, 2024 |
| 4 | FORM 4 | 0001437749-24-029387 | Sep 17, 2024 | Sep 15, 2024 |
| 4 | FORM 4 | 0001437749-24-029388 | Sep 17, 2024 | Sep 15, 2024 |
| 8-K | FORM 8-K | 0001437749-24-029392 | Sep 17, 2024 | Sep 15, 2024 |
| SC 13D/A | SCHEDULE 13D/A | 0001437749-24-027668 | Aug 23, 2024 | — |
| SC 13D/A | SCHEDULE 13D/A | 0001437749-24-027667 | Aug 23, 2024 | — |
| 8-K/A | FORM 8-K/A | 0001437749-24-027621 | Aug 22, 2024 | Aug 20, 2024 |
| 424B5 | FORM 424B5 | 0001437749-24-027562 | Aug 22, 2024 | — |
| UPLOAD | — | 0000000000-24-009628 | Aug 22, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-027511 | Aug 21, 2024 | Aug 20, 2024 |
| 8-K | FORM 8-K | 0001437749-24-026567 | Aug 14, 2024 | — |
| 10-Q | FORM 10-Q | 0001437749-24-026571 | Aug 14, 2024 | Jun 30, 2024 |
| SC 13G | — | 0001319244-24-000047 | Aug 14, 2024 | — |
| CORRESP | — | 0001437749-24-025215 | Aug 7, 2024 | — |
| UPLOAD | — | 0000000000-24-008391 | Jul 24, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-022354 | Jul 9, 2024 | — |
| SC 13D/A | — | 0001493152-24-022270 | May 31, 2024 | — |
| 424B5 | FORM 424B5 | 0001437749-24-018516 | May 29, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-018540 | May 29, 2024 | May 28, 2024 |
| S-8 | FORM S-8 | 0001437749-24-017496 | May 17, 2024 | — |
| 8-K | FORM 8-K | 0001437749-24-016796 | May 15, 2024 | — |